Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab + nab-paclitaxel versus placebo + nab-paclitaxel in previously untreated metastatic triple-negative breast cancer
2014-005490-37Phase 3Completed
- Sponsor
- Roche
- Start
- Mar 2015
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of atezolizumab, paclitaxel in triple-negative breast cancer (TNBC), breast cancer, sponsored by Roche. Started Mar 2015; status: completed.
02
Drugs
atezolizumabpaclitaxel
03
Conditions
triple-negative breast cancer (TNBC)breast cancer
Beyond the preview
Go deeper on 2014-005490-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005490-37.